04:12 PM EDT, 09/26/2024 (MT Newswires) -- Richard Mulligan, Director, on September 24, 2024, sold 300,000 shares in Sana Biotechnology ( SANA ) for $1,195,740. Following the Form 4 filing with the SEC, Mulligan has control over a total of 2,698,121 shares of the company, with 2,698,121 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1770121/000156218024006954/xslF345X05/primarydocument.xml